Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.

Methamphetamine (METH) is a potent psychostimulant with neurotoxic properties. Heavy use increases the activation of neuronal nitric oxide synthase (nNOS), production of peroxynitrites, microglia stimulation, and induces hyperthermia and anorectic effects. Most METH recreational users also consume c...

Descrizione completa

Dettagli Bibliografici
Autori principali:	M Paola Castelli, Camilla Madeddu, Alberto Casti, Angelo Casu, Paola Casti, Maria Scherma, Liana Fattore, Paola Fadda, M Grazia Ennas
Natura:	Articolo
Lingua:	English
Pubblicazione:	Public Library of Science (PLoS) 2014-01-01
Serie:	PLoS ONE
Accesso online:	http://europepmc.org/articles/PMC4028295?pdf=render

Documenti analoghi

Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation
di: Salvatore Lecca, et al.
Pubblicazione: (2019-09-01)

Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol
di: Černe Katarina
Pubblicazione: (2020-03-01)

The Pharmacokinetics of Δ<sup>9</sup>-Tetrahydrocannabinol in Sheep
di: Sarah A. Stevens, et al.
Pubblicazione: (2024-11-01)

Quantification and prediction of human fetal (-)-Δ9-tetrahydrocannabinol/(±)-11-OH-Δ9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity
di: Aditya R. Kumar, et al.
Pubblicazione: (2025-01-01)

Δ9-tetrahydrocannabinol discrimination: Effects of route of administration in mice
di: Julie A. Marusich, et al.
Pubblicazione: (2023-12-01)

The dimerization of Δ9-tetrahydrocannabinolic acid A (THCA-A)
di: Arben Cuadari, et al.
Pubblicazione: (2019-09-01)

Acute human exposure assessment to tetrahydrocannabinol (Δ9‐THC)
di: European Food Safety Authority (EFSA), et al.
Pubblicazione: (2020-01-01)

Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol
di: Elisa Landucci, et al.
Pubblicazione: (2022-01-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
di: Qianru Rao, et al.
Pubblicazione: (2022-11-01)

Selective effects of Δ9-tetrahydrocannabinol on medium spiny neurons in the striatum.
di: Mónica R Fernández-Cabrera, et al.
Pubblicazione: (2018-01-01)

Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments.
di: Jenny L Wilkerson, et al.
Pubblicazione: (2019-01-01)

Detection of Δ9-tetrahydrocannabinol (THC) in hair using GC–MS
di: Himanshu Khajuria, et al.
Pubblicazione: (2014-03-01)

Hydroxylation and glycosylation of Δ9-tetrahydrocannabinol by Catharanthus roseus cell suspension culture
di: Akhtar, Muhammad Tayyab, et al.
Pubblicazione: (2015)

Smoking or Vaping Cannabis and Cardiovascular Function: Is Δ‐9‐Tetrahydrocannabinol the Main Culprit?
di: Onyedika J. Ilonze, et al.
Pubblicazione: (2024-12-01)

Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain
di: Alejandra Escudero-Lara, et al.
Pubblicazione: (2020-01-01)

Cannabis Use and Neuroadaptation: A Call for Δ9-Tetrahydrocannabinol Challenge Studies
di: Johannes G. Ramaekers, et al.
Pubblicazione: (2022-04-01)

Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
di: Johannes Beiersdorf, et al.
Pubblicazione: (2020-12-01)

Screening microbially produced Δ9-tetrahydrocannabinol using a yeast biosensor workflow
di: William M. Shaw, et al.
Pubblicazione: (2022-09-01)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
di: Wanuttha Boonyayothin, et al.
Pubblicazione: (2022-06-01)

Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
di: Diana E. Sepulveda, et al.
Pubblicazione: (2022-10-01)

Methamphetamine neurotoxicity, microglia, and neuroinflammation
di: Fatemeh Shaerzadeh, et al.
Pubblicazione: (2018-12-01)

Proteomic Profile of Circulating Extracellular Vesicles in the Brain after Δ9-Tetrahydrocannabinol Inhalation
di: Valeria Lallai, et al.
Pubblicazione: (2024-09-01)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
di: Lourdes Poyatos, et al.
Pubblicazione: (2020-06-01)

A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol
di: Salahaden R. Sultan, et al.
Pubblicazione: (2018-01-01)

Anticancer activity of Δ9-tetrahydrocannabinol and cannabinol in vitro and in human lung cancer xenograft
di: Surang Leelawat, et al.
Pubblicazione: (2022-01-01)

Δ9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008
di: MAJA DJURENDIĆ-BRENESEL, et al.
Pubblicazione: (2010-07-01)

Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity
di: Éric Samarut, et al.
Pubblicazione: (2019-03-01)

Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction
di: Xinwen Chang, et al.
Pubblicazione: (2017-06-01)

Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function.
di: Matthijs G Bossong, et al.
Pubblicazione: (2013-01-01)

Evaluation of Δ9-tetrahydrocannabinol metabolites and oxidative stress in type 2 diabetic rats
di: Zeynep Coskun, et al.
Pubblicazione: (2016-02-01)

Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice
di: Cory Parks, et al.
Pubblicazione: (2021-07-01)

Hexahydrocannabinol (HHC) and Δ9-tetrahydrocannabinol (Δ9-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling
di: Oleh Durydivka, et al.
Pubblicazione: (2024-04-01)

Bacopa Protects against Neurotoxicity Induced by MPP<sup>+</sup> and Methamphetamine
di: Michela Ferrucci, et al.
Pubblicazione: (2022-08-01)

Δ9-Tetrahydrocannabinol (Δ9-THC) Improves Ischemia/Reperfusion Heart Dysfunction and Might Serve as a Cardioprotective Agent in the Future Treatment
di: Marta Banaszkiewicz, et al.
Pubblicazione: (2022-04-01)

Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.
di: Nina L Cluny, et al.
Pubblicazione: (2015-01-01)

Antidepressant-like effects of Δ9-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression
di: Mohamed Elbatsh, Maha, et al.
Pubblicazione: (2012)

Enrichment and identification of Δ9-Tetrahydrocannabinolic acid synthase from Pichia pastoris culture supernatants
di: Kerstin Lange, et al.
Pubblicazione: (2015-09-01)

Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation
di: Anthony Murkar, et al.
Pubblicazione: (2019-08-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
di: Swapnali Chetia, et al.
Pubblicazione: (2020-08-01)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
di: Joseph J. Wakshlag, et al.
Pubblicazione: (2020-09-01)